Clinical Study
AT100-01: An AAV8 Neutralizing Antibody Seroprevalence Study in Subjects with Late Onset Pompe Disease
Patients with Pompe disease on a stable enzyme replacement therapy or naive to treatment are invited to come to clinic for a one time visit. This visit will include review of medical records and a blood draw to determine if you have antibodies against AAV8.
For more information contact:
Carrie Bailey
carrie.bailey@umail.utah.edu
8015873605
IRB#: IRB_00131563
| PI: Nicola Longo
| Department: PEDIATRIC GENETICS
| Approval Date: 2020-06-25 14:02:00
Specialties: Pediatric Genetics
Who can participate?
Gender: All
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Will I be paid for my time?
Yes